NCT00747721

Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU

Pharmacokinetics of Intravenous Dexmedetomidine for Prolonged Infusion in Critically Ill, Ventilated Patients in Intensive Care Unit; an Open, Non-Randomised, Single Centre Study

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: Orion Corporation, Orion Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study will examine dexmedetomidine levels in the blood of critically ill intensive care patients to understand how it is broken down by the body.

Conditions

• Pharmacokinetics
• Sedation

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	2 ml ampoule containing 200 micrograms dexmedetomidine for dilution with 48 ml 0/9% sodium chloride injection. Titrated to efficacy.

Timeline

• Start date: 2008-09-01
• Primary completion: 2009-01-01
• Completion: 2009-02-01
• First posted: 2008-09-05
• Last updated: 2009-04-21

Locations

1 site across 1 country: Finland